NPPB and COVID-19: Data from meta-analyses further highlight the prognostic value of the cardiac markers, both Brain natriuretic peptides (BNP), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) with regard to mortality and disease severity in patients with COVID-19 (28, 30–34).